Cancer Center Amsterdam
-
Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL
Campanella, A., Capasso, A., Heltai, S., Albi, E., Herishanu, Y., Haggenburg, S., Chatzikonstantinou, T., Doubek, M., Kättström, M., Giannopoulos, K., Simkovic, M., Moreno, C., Massaia, M., Bumbea, H., Alshemmari, S., Ranghetti, P., Perotta, E., Martini, F., Sant'Antonio, E., Colia, M., & 23 others, Apr 2024, In: American journal of hematology. 99, 4, p. 745-750 6 p.Research output: Contribution to journal › Letter › Academic › peer-review
-
Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study
COBRA KAI Study Team, 1 Jul 2023, In: EClinicalMedicine. 61, 102040.Research output: Contribution to journal › Article › Academic › peer-review
-
Immunogenicity of the 13-Valent Pneumococcal Conjugated Vaccine Followed by the 23-Valent Polysaccharide Vaccine in Chronic Lymphocytic Leukemia
Haggenburg, S., Garcia Garrido, H. M., Kant, I. M. J., van der Straaten, H. M., de Boer, F., Kersting, S., Issa, D., te Raa, D., Visser, H. P. J., Kater, A. P., Goorhuis, A. & de Heer, K., 1 Jul 2023, In: Vaccines. 11, 7, 1201.Research output: Contribution to journal › Article › Academic › peer-review
- All publications